Menu Search
Equities

Sareum Holdings PLC

  • Add to watchlist
  • Add to portfolio
  • Add an alert
SAR:LSE

Sareum Holdings PLC

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (GBX)18.00
  • Today's Change0.00 / 0.00%
  • Shares traded149.43k
  • 1 Year change-48.57%
  • Beta-1.4705
Data delayed at least 20 minutes, as of Jul 18 2025 14:29 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Year on year Sareum Holdings PLC's net income fell 7.14% from a loss of 3.19m to a larger loss of 3.42m despite flat revenues.
Gross margin--
Net profit margin--
Operating margin--
Return on assets-62.11%
Return on equity-75.24%
Return on investment-75.24%
More ▼

Cash flow in GBPView more

In 2024, Sareum Holdings PLC increased its cash reserves by 46.78%, or 465.00k. Cash Flow from Financing totalled 4.38m or -- of revenues. In addition the company used 3.92m for operations while cash from investing totalled 9.00k.
Cash flow per share-0.0191
Price/Cash flow per share--
Book value per share0.0347
Tangible book value per share0.0347
More ▼

Balance sheet in GBPView more

Sareum Holdings PLC has little financial risk as the capital structure does not rely on leverage.
Current ratio12.53
Quick ratio--
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.